drugset / Trial / NCT06636877

A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1019" and Co-administration of "BR1019-3" and "BR1019-2" in Healthy Volunteers

NCT06636877 ↗

Phase 1 Completed 52 enrolled Boryung Pharmaceutical Co., Ltd
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this clinical trial is to evaluate the pharmacokinetics and the safety after administration of "BR1019" and co-administration of "BR1019-3" and "BR1019-2" in healthy volunteers

Timeline

Start
2024-10-23
Primary completion
2024-12-11
Completion
2024-12-11

Drugs

EvaluationDrugModalityDoseRoute
Subject BR1019 Unknown — —
Comparator BR1019-2 Unknown — —
Comparator BR1019-3 Unknown — —